EmCell Cell Therapy Center
EmCell Cell Therapy Center
Ukraina, Kyiv
| Turki | Austria | Spanyol | |
| Pengobatan hipertensi pulmonal dengan sel punca | ≈ $7,500 | ≈ $12,000 | ≈ $9,500 |
Bookimed tidak menambah biaya tambahan dalam harga Pengobatan hipertensi pulmonal dengan sel punca. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik untuk Pengobatan hipertensi pulmonal dengan sel punca Anda saat tiba.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam Pengobatan hipertensi pulmonal dengan sel punca dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan Pengobatan hipertensi pulmonal dengan sel punca Anda.
Dr. Dogan Erdogan berspesialisasi dalam pengobatan hipertensi pulmonal dengan terapi sel punca di Medical Park Antalya Hospital Complex.
Dr. Fatih Koç membawa pengalaman khusus dari Unit Kardiologi Invasif Cleveland Clinic, dengan fokus pada kondisi jantung dan paru-paru.
Dr. Gokhan Bektasoglu is a cardiologist trained at the Faculties of Medicine of Hacettepe University and Cumhuriyet University. He has worked at Medicine Hospital (2014). He also served at Private European Dawn Hospital, Atrium Cardiology Center (2012–2014); Izmir Karşıyaka State Hospital (2011–2012); Okmeydanı Training and Research Hospital (2011); and Uzunköprü State Hospital (2009–2011).
His clinical focus includes coronary and peripheral angiography with balloon and stent procedures. He performs carotid stenting, EVAR, and TEVAR. He is experienced in echocardiography and TEE. He manages device therapy (pacemaker, ICD, CRT) and arrhythmias. He treats heart failure. He performs ASD and VSD closure. He also offers valve therapies, including TAVI, mitral balloon valvuloplasty, and MitraClip. He has published in the American Journal of Cardiology, American Journal of Emergency Medicine, Journal of Thrombosis and Thrombolysis, European Journal of Echocardiography, Bratislava Medical Journal, and International Journal of Angiology. He has presented at international cardiology meetings.
Dr. Xu Juntang, MD, is a Postdoctoral Fellow, Chief Physician, and Master’s Supervisor. He is the Director of Cardiovascular Medicine at Xiamen Humanity Hospital. His work focuses on preventing and treating cardiovascular and thrombotic diseases, including coronary artery disease, hypertension, heart failure, arrhythmias, and emergencies. He is skilled in cardiovascular biomarker testing.
He provides standardized care for thromboembolism related to valvular heart disease and non‑valvular atrial fibrillation, pulmonary embolism, deep vein thrombosis, and obstetric thrombophilia. He also conducts clinical and laboratory assessments of thrombosis and coagulation disorders. He is the Vice Chairman of the Laboratory and Clinical Branch of the Chinese Society of Cardiothoracic and Vascular Anesthesiology.